Pages that link to "Q38928320"
Jump to navigation
Jump to search
The following pages link to Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis (Q38928320):
Displaying 10 items.
- Tumor segmentation of whole-body magnetic resonance imaging in neurofibromatosis type 1 patients: tumor burden correlates. (Q39213525) (← links)
- Clinical Value of Multiparametric Whole-Body Magnetic Resonance Imaging over Whole-Spine Magnetic Resonance Imaging in Patients with Neurofibromatosis Type I. (Q47630595) (← links)
- Diffusion weighted imaging demystified: the technique and potential clinical applications for soft tissue imaging (Q49844245) (← links)
- Current utilization and procedural practices in pediatric whole-body MRI. (Q54222276) (← links)
- Oral plexiform schwannoma: A case report and relevant immunohistochemical investigation (Q64077780) (← links)
- Diffusion-weighted imaging and diffusion tensor imaging as adjuncts to conventional MRI for the diagnosis and management of peripheral nerve sheath tumors: current perspectives and future directions (Q90393780) (← links)
- Longitudinal phenotype development in a minipig model of neurofibromatosis type 1 (Q90471420) (← links)
- Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives (Q97543634) (← links)
- Computed Tomography-Based Differentiation of Benign and Malignant Craniofacial Lesions in Neurofibromatosis Type I Patients: A Machine Learning Approach (Q98771173) (← links)
- The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas (Q99558426) (← links)